Jan. 8, 2014

PHA News, Pulmonary Hypertension Association, Empowered by hope
Blog Post from PHA's President

Moving into 2014...

Just before we ended 2013, I wrote to PHA’s Board of Trustees and other leaders about what an amazing year it had been… and where we were headed in 2014. I’d like to open the year by sharing some of those thoughts with you. » Read more

New Pulmonary Hypertension Drug Approved

New PH Drug Marks Twelfth Option for Disease

On Dec. 20, 2013, the U.S. Food and Drug Administration (FDA) approved United Therapeutics' oral treprostinil, an extended-release tablet commercially known as Orenitram, for the treatment of pulmonary arterial hypertension (PAH). Orenitram is the first orally administered prostacyclin analogue approved by the FDA for any disease. » Read more

From the PH Community
    2014 Road

Generation Hope Blog: The Unpredictable Road Ahead

It’s the New Year 2014, and we made it through the obstacles of 2013. However, it doesn't mean that 2014 is guaranteed to be easier than the previous year. Life is a journey, or perhaps it is more like a cross-country road trip with family and/or friends, and you will have great moments and memories along the trip. » Read Kiara's story

Online Education for Patients & Families
    PHA Classroom

View PHA Classroom Webinar Recordings

Did you miss a recent PHA Classroom e-learning event? There’s still a chance to receive the education you want. Recordings of all past PHA Classroom webinars and Conference sessions are archived on PHA Classroom. Recent recordings include:

  • Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease
  • Surviving Survivor's Guilt
  • Chronic Thromboembolic Pulmonary Hypertension – What You Need to Know
  • Exercise-Induced Pulmonary Hypertension – What Is It and What Do We Do About It?

» View recordings

PH News Headlines



Research & Treatment News
» Research Breakthroughs Advance Understanding of Genetic Causes of Vascular Disease

Updates From PHers Around the World
» Women in Government Launches a Pulmonary Hypertension Legislative Toolkit

» Paving the Way for Pulmonary Hypertension Treatment

» Granville Summit Woman Wages Health Battle

» More News

with PHA


Telephone Support

Jan. 15, 2014
1:30 p.m. ET/10:30 a.m. PT

Jan. 20, 2014
8 p.m. ET/5 p.m. PT

Jan. 20, 2014
11 p.m. ET/8 p.m. PT

Jan. 23, 2014
8 p.m. ET/5 p.m. PT

Upcoming Events

Jan. 21, 2014
PHA Classroom Webinar: Newly Diagnosed Self-Study: PH Ready and PH Ready Caregivers Wrap-Up

Jan. 30, 2014
PHA Classroom Webinar: Newly Diagnosed? What You Need to Know

» Go to the Events Calendar

Video Spotlight

Traveling Hope Road

Last summer, PH patient Diane Leavitt drove across the country on a journey she calls “Traveling Hope Road.” As she went, she visited PH patients and others, filming interviews and creating a documentary. View her documentary

Need more information? Contact
Pulmonary Hypertension Association 801 Roeder Road, Ste. 1000 Silver Spring, MD 20910
Office: 301-565-3004 | Fax: 301-565-3994

Privacy Policy | Unsubscribe/Email Preferences

Copyright © 2014 Pulmonary Hypertension Association.
All Rights Reserved.




Not already subscribed? Sign up for PHANews

FacebookTwitterInstagram iconLinkedInYouTube

For optimal viewing of, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2016 Pulmonary Hypertension Association. All Rights Reserved.


The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.